News Tag: Newsletter

Advocate Angle: “Life’s a journey – travel well”

Read More

Advocate Angle: Improving the Cancer Clinical Trial Matching Ecosystem

Read More

FORTE Study Updates: November 2024

Read More

NRG-GU011 (“NRG PROMETHEAN”): stereotactic radiotherapy with or without relugolix for PET-recurrent oligometastatic prostate cancer

Read More

Moving anti-HER2 therapy into the peri-operative setting for locally advanced esophagogastric cancer

Read More

SBRT to the Primary Tumor Followed by Conventional Radiation Therapy and Chemotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer (NRG-LU008)

Read More

FORTE Study Updates: October 2024

Read More

Advocate Angle: An Interview with Laurel Pracht: Making Strides to Fund the Future in Ovarian Cancer Research

Read More